Takeda Pharmaceutical Company Limited Increase Decrease Through Share-based Payment Transactions
Takeda Pharmaceutical Company Limited (TKPHF) reported Increase Decrease Through Share-based Payment Transactions of JPY 74.71 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions · last filed 2025-06-25
| Period end | Increase Decrease Through Share-based Payment Transactions 12 month |
|---|---|
| 2025-03-31 | 74.71B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 69.84B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 62.67B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 43.37B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 37.66B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 29.12B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 20.10B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 18.61B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 15.32B JPY 20-F · filed 2019-06-27 |